Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
Clinical trial NCT01845428 · COMPLETED
Trial details
- NCT number
- NCT01845428
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2017-01-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.